Calyx Institute in Surrey, UK, has become a key employer for the UK Government, as it has helped deliver £3.5bn of new spending on skin care, including more than half a million new jobs over the past four years.
The institute, founded in 1991, has a population of about 1,500 staff, and employs around 600 people.
It is currently ranked among the top 10 UK skin and facial cancer centres, with around a quarter of its staff having received a facial cancer diagnosis.
“We’re not just looking after our own people.
We’re looking after the entire population of the UK,” Dr Caroline Waugh, a senior researcher at the institute, told Business Insider.
“We have a huge amount of work to do in order to bring people back into the workforce and to improve the NHS.”
The institute is a key player in a government effort to reduce skin cancer.
In 2018, the government announced £4.7bn in funding for the Calyx NHS Foundation Trust to fund skin care projects across the country.
The trust’s first project, the Skin Cancer Partnership, is one of a series of skin cancer services being launched across the UK.
The NHS Foundation trust, a publicly funded health service in the United Kingdom, runs the Calyps NHS Foundation, which is the only UK-based NHS skin and face cancer centre.
It has more than 1,000 staff in its five hospitals and clinics across England, Wales, Scotland and Northern Ireland.
Dr Waugh said the foundation has been instrumental in bringing together the community and working with a number of NHS partners to address skin cancer, which had previously been considered a rare disease.
“It’s been the main part of our efforts in bringing about these new programmes,” she said.
For Dr Waugh and her colleagues, this was not only a job but also a vital role.
They work to help patients with their skin cancers.
As part of the project, they help patients identify the risk factors, manage their symptoms and identify how best to manage their condition.
There are now skin cancer patients in Calypsy and the other UK cancer centres who have had a facial diagnosis and were referred to the foundation’s clinics.
To date, the foundation is helping close a number.
More than 60 per cent of Calypy’s facial cancer patients are now covered by the Calyppse program, and Dr Waugus said the work they do is a significant part of what makes the programme such a success.
She added: “It’s not just about getting people back to work.
It’s also about getting them back to feel good about themselves.”
Dr Jodie Mackey, chair of the Royal College of General Practitioners, said the new research showed that it was important for government to be involved in helping people find jobs, and that it should be more transparent about the funding that is being used to fund these projects.
We are at a very exciting time in the NHS, where skin cancer is on the rise, and we are committed to ensuring the future health of our patients, she said, adding: “We need a better NHS and more skin cancer centres to make sure we get the most out of this exciting time.”
A spokesperson for Calypsey said: “Calypsey works with the NHS to support our patients to make the most of life and develop healthy skin and achieve self-confidence.
Our work is backed by the UK Department for Business, Innovation and Skills (BIS), with over £5bn allocated to support the development of new jobs in skin care and in the skin cancer field over the last four years.”
Follow Business Insider UK on Facebook, Twitter and Instagram.